Parker Waichman LLP

Zocor/Simvastatin Side Effect Lawsuit

Zocor/Simvastatin Injury Lawsuits. The maximum dosage (80mg) of the cholesterol-lowering drug Zocor (simvastatin) can result in an increased risk of Myopathy, a severe type of muscle injury and Rhabdomyolysis during the first 12 months of treatment as stated in a recent report released June 8, 2011 by the FDA.The defective drug attorneys at Parker Waichman […]

Zocor/SimvastatinZocor/Simvastatin Injury Lawsuits. The maximum dosage (80mg) of the cholesterol-lowering drug Zocor (simvastatin) can result in an increased risk of Myopathy, a severe type of muscle injury and Rhabdomyolysis during the first 12 months of treatment as stated in a recent report released June 8, 2011 by the FDA.The defective drug attorneys at Parker Waichman LLP are currently evaluating potential lawsuits for individuals that have experience muscle injury, skeletal muscle tissue breakdown or any of the side effects associated with taking the maximum dosage of Zocor/Simvastatin. Patients taking the highest dosage of Zocor – 80 mg – during their first year of treatment face the greatest risk of muscle injury.

At its most severe, Zocor muscle injury can lead to rhabdomyolysis, a disorder that can damage the kidneys and lead to kidney failure and possibly death. Approximately 5 out of 100,000 individuals suffering from Zocor rhabdomyolysis side effects who were prescribed the 80mg dose had to be hospitalized.

If you took Zocor or another simvastatin product and were diagnosed with myopathy or rhabdomyolysis, our Zocor muscle injury lawyers want to hear from you today. You may be able to receive compensation for you pain and suffering by filing a rhabdomyolysis lawsuit. Our Zocor muscle injury lawyers are offering victims of this drug free lawsuit evaluations, so please contact us today or call us today at 1-800-YOURLAWYER (1-800-968-7529) to protect you legal rights.

Zocor/Simvastatin Maximum Dosage Muscle Injury Warnings

According to researchers at the University of Missouri, statins such as Zocor might prevent obese patients from getting the full benefits of exercise despite the fact that this is a crucial element of preventing heart disease. The researchers conducted a study where 37 overweight, sedentary individuals between the ages of 26 and 59 were out on a 12 week exercise regimen; 18 were taking a statin. After 12 weeks, the exercise-only group had performed significantly better on two health measures compared to the statin group. Those taking a statin only increased their cardiorespiratory fitness by 1.5 percent on average while the exercise only group boosted their fitness by 10 percent. The non-statin group also did better when it came to skeletal muscle mitochondrial content, the site where oxygen is turned into energy by muscles; in the exercise-only group this increased 13 percent but in the statin group it dropped 4.5 percent.

simvastatin

Zocor is part of a class of drugs called statins that are used to treat high LDL (bad) cholesterol. Simvastatin is also sold in generic versions, and is an active ingredient in the combination drugs Vytorin and Simcor. Muscle injury has long been recognized as a possible statin side effect, and the labels of these medications all bear warnings regarding this risk. In 2010, the U.S. Food and Drug Administration (FDA) updated the labels of high-dose simvastatin to warn of an association with muscle injuries.

On June 8, 2011, the FDA added new warnings to the labels of Zocor and other simvastatin (cholesterol-lowering) drugs and recommended that patients not be prescribed the 80 mg dose during the first 12 months of treatment in order to mitigate the Zocor muscle injury risk. The new restrictions and warnings also apply to Vytorin and Simcor. In addition, the labels for simvastatin, Vytorin and Simcor were changed to include new dosing recommendations when these drugs are used with certain medications, such as blood pressure medicines amlodipine and diltiazem, which interact to increase the level of simvastatin in the body, which can increase the risk for myopathy.

The FDA’s action was prompted by a seven-year study and patient reports that prove those taking the higher dosage of simvastatin have a greater risk of muscle injury than patients treated with lower doses or other statins. The agency said its review of a trial called the Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH) revealed 52 cases of myopathy occurring in the group of patients treated with 80 mg simvastatin versus one in the group treated with 20 mg. Twenty-two patients in the 80-mg group developed rhabdomyolysis, while none in the 20-mg group developed the disorder.

The risks for myopathy and rhabdomyolysis with simvastatin 80 mg were highest in the first 12 months of treatment, 5 per 1000 person-years and 2 per 1000 person-years, respectively, and decreased to 1 per 1000 person-years and 0.4 per 1000 person-years after that, the FDA said.

An analyses of the FDA’s Adverse Event Reporting System (AERS) database also showed that the level of reporting of fatal rhabdomyolysis associated with the 80-mg dose of simvastatin has been higher in comparison with lower doses of simvastatin or lower doses of most other statins, the agency said.

Zocor May Counteract the Benefits of Exercise in Obese Patients

According to researchers at the University of Missouri, statins such as Zocor might prevent obese patients from getting the full benefits of exercise despite the fact that this is a crucial element of preventing heart disease. The researchers conducted a study where 37 overweight, sedentary individuals between the ages of 26 and 59 were out on a 12 week exercise regimen; 18 were taking a statin. After 12 weeks, the exercise-only group had performed significantly better on two health measures compared to the statin group. Those taking a statin only increased their cardiorespiratory fitness by 1.5 percent on average while the exercise only group boosted their fitness by 10 percent. The non-statin group also did better when it came to skeletal muscle mitochondrial content, the site where oxygen is turned into energy by muscles; in the exercise-only group this increased 13 percent but in the statin group it dropped 4.5 percent.

Legal Help for Victims of Zocor Muscle Injuries

If you suffered from myopathy or rhabdomyolysis because of Zocor, you have valuable legal rights. To find out how our Zocor injury lawyers can help you receive compensation for your injuries, please fill out our online form or call 1-800-YOURLAWYER (1-800-968-7529) today.

What Our Clients Say About Us
We have worked with thousands of clients and we appreciate them and their positive reviews. Here are just a few recent client reviews...
5 Star Reviews 150
Has kept me up to date on everything, i am very pleased with their services.
Bria Fuller
6 years ago
5 Star Reviews 150
Positive: Professionalism , Quality , Responsiveness
Jairo Blanco
2 years ago
5 Star Reviews 150
I understand that process for a case like mine takes time.Parker Wakeman has been working on it for me since my injury in August of 2014.There have been times where frustration has arrived during this period.I can't express my appreciation enough to my paralegal Josephine Burgess-Zephrine .She keeps me updated and aware of everything that goes on.I wish it was over,but I appreciate all that Josephine & Parker Wakeman are doing for me. Sincerely
Bob Schmitt
5 years ago

Why Choose Us to Help You?

We Take Care of Everything
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
No Recovery = No Legal Fees
We work on a contingency-fee basis, meaning that we only get paid from a portion of your settlement or jury award. If you don't get compensation, you owe us nothing.
Decades of Experience
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
Respected by Our Peers
Judges, insurance adjusters, and fellow attorneys all speak highly of our skills, and we've earned numerous accolades, including a flawless rating from AVVO.
We Have Many Locations To Serve You
We have the experience and the skilled litigators to win your case. Contact us and speak with a real attorney who can help you.
Long Island – Nassau
Parker Waichman LLP
6 Harbor Park Drive
Port Washington, NY 11050
Long Island – Suffolk
Parker Waichman LLP
201 Old Country Road – Suite 145
Melville, NY 11747
New York
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038
Queens
Parker Waichman LLP
118-35 Queens Boulevard, Suite 400
Forest Hills, NY 11375
Brooklyn
Parker Waichman LLP
300 Cadman Plaza West
One Pierrepont Plaza, 12th Floor
Brooklyn, NY 11201
New Jersey
Parker Waichman LLP
80 Main Street, Suite 265
West Orange, NJ 07052
Florida
Parker Waichman LLP
27299 Riverview Center Boulevard
Suite 108
Bonita Springs, FL 34134
Nationwide Service
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038